Intramuscular Midazolam Versus Intravenous Diazepam for Acute Seizure in Children
Launched by AROOJ KHAN · Feb 14, 2024
Trial Information
Current as of July 05, 2025
Completed
Keywords
ClinConnect Summary
A seizure or convulsion is a time-limited, paroxysmal, change in motor activity and or behavior that results from electrical activity in the brain that is abnormal.1 The emergency department of a hospital is usually the place where children with seizures receive first treatment and medical support. Seizures make up about 1% of all emergency department visits for pediatric patients, and at least 5% of pediatric patients will have a seizure by the time they are 16 years old. Children younger than one year of age are commonly affected by new and unprovoked seizures.2 Seizures can result in con...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients presented to the pediatric emergency, with all types of seizures, aged 3 months to 5 years.
- Exclusion Criteria:
- • 1. Children who already had intravenous access. 2. Children who had signs of clinical heart failure like tachycardia, tachypnea, and hepatomegaly.
- • 3. Children who had any severe systemic disease like renal disorder, liver disorder, and Beta Thalassemia major.
- • 4. Known allergy to midazolam or diazepam 5. Children who had hypoglycemia as the known cause of seizure 6. Children with other known causes of fits, like hypocalcemia, CKD, Hypoparathyroidism, Renal Tubular Acidosis
About Arooj Khan
Arooj Khan is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on integrity and excellence, Arooj Khan oversees the design, implementation, and management of clinical trials across various therapeutic areas. The organization emphasizes collaboration with healthcare professionals and regulatory bodies to ensure adherence to the highest standards of safety and efficacy. By leveraging cutting-edge technology and data-driven methodologies, Arooj Khan strives to bring groundbreaking treatments to market, ultimately enhancing the quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Peshawar, , Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported